Researchers identified miR-362-5p as a potential biomarker for diabetic eye disease, reporting elevated levels in diabetic retinopathy that track with disease severity. The study also tied the microRNA to retinal endothelial cell injury under high glucose by targeting CCND2, supporting a biomarker-and-mechanism pairing that could inform patient stratification or therapeutic targeting.